# MPM Capital: portfolio, investments and team

> MPM Capital is a private equity based in United States. 139 investments on record, 1 in the last 12 months, latest Dec 2025.

Source: https://millionrounds.com/fund/mpm-bioimpact (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# MPM Capital

Last cheque observed Dec 2025; 139 cheques on record.

Deploying now New fund $407K, Jun 2026 Private equity Now at mpmbioimpact.com

Pre-seed Seed Series A Molecules Ivd Medical Devices

Deploying now

**100%** of best year **1** **cheques in 12 months**, 139 on record

Since the last cheque **329** days **00** hrs **00** min **00** sec

Median round **$60M** Rounds led **2 of 139** Sole investor **8 rounds** Exits **23 from the portfolio** Mostly in **United States, 97%**

Pitch MPM Capital

## MPM Capital highlights

- 01 1 cheques in the last 12 months
- 02 Mostly Series B and Series A: 51% of its rounds
- 03 Sole investor in 8 rounds, median $10M
- 04 23 exits from the portfolio

## What they do

> Filed 1 private fund offering with the SEC, the most recent in 2020-02 From their own website

- **Type:** Private equity (from a list, unverified)
- **Cheque size:** Up to $150M as they say
- **Stages:** Pre-seed Seed Series A Series B Growth
- **Sectors:** Molecules Ivd Medical Devices
- **Based in:** Boston, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **139 appearances**

- **2025** 1 round
- **Dec** **[Protego Biopharma](https://millionrounds.com/company/protego-biopharma)** Series B · US · Firms' own news pages **$130M** With 9 others
- **2023** 1 round
- **Oct** **[AstronauTx](https://millionrounds.com/company/astronautx)** Series A · GB · UCL Technology Fund **$61M** With 7 others
- **2019** 4 rounds
- **Dec** **[Tripley Therapeutics](https://millionrounds.com/company/tripley-therapeutics)** Series A · US · FinSMEs **$59M** With 1 other
- **Nov** **[Wereworld Therapeutics](https://millionrounds.com/company/wereworld-therapeutics)** Series A · US · FinSMEs **$56M** *Led*
- **Sept** **[Amphivena](https://millionrounds.com/company/amphivena)** Series C · US · FinSMEs **$62M** With 10 others
- **Jun** **[Frontier Medicines](https://millionrounds.com/company/frontier-medicines)** Series A · US · FinSMEs **$67M** *Led*
- **2018** 2 rounds
- **Sept** **[Coda Therapeutics](https://millionrounds.com/company/coda-therapeutics)** Series A · US · FinSMEs **$19M** With 2 others
- **Sept** **[27-8 Therapeutics](https://millionrounds.com/company/27-8-therapeutics)** Series A · US · FinSMEs **$65M** With 4 others
- **2017** 2 rounds
- **Oct** **[Cullinan Oncology](https://millionrounds.com/company/cullinan-oncology)** Series A · US · FinSMEs **$150M** With 1 other
- **May** **[Harpoon Therapeutics](https://millionrounds.com/company/harpoon-therapeutics)** Series B · FinSMEs **$45M** With 3 others
- **2016** 2 rounds
- **Aug** **[Iconic Therapeutics](https://millionrounds.com/company/iconic-therapeutics)** Series C · US · FinSMEs **$10M** With 2 others
- **Jul** **[Oncorus](https://millionrounds.com/company/oncorus)** Series A · US · Xconomy **$57M** Sole investor
- **2015** 6 rounds
- **Dec** **[True North Therapeutics](https://millionrounds.com/company/true-north-therapeutics)** Series C · US **$40M** With 5 others
- **Aug** **[Syndax Pharmaceuticals](https://millionrounds.com/company/syndax-pharmaceuticals)** Series C · US **$80M** With 12 others
- **Aug** **[Rhythm Pharmaceuticals](https://millionrounds.com/company/rhythm-pharmaceuticals)** Series A · US **$40M** With 7 others
- **Apr** **[True North Therapeutics](https://millionrounds.com/company/true-north-therapeutics)** Series B · US **$35M** With 4 others
- **Mar** **[Semma Therapeutics](https://millionrounds.com/company/semma-therapeutics)** Series A · US **$44M** With 3 others
- **Mar** **[Clinical Ink](https://millionrounds.com/company/clinical-ink)** Venture · US **$20M** With 2 others
- **2014** 4 rounds
- **Oct** **[Raze Therapeutics](https://millionrounds.com/company/raze-therapeutics)** Series A · US **$24M** With 6 others
- **Jul** **[Cerecor](https://millionrounds.com/company/cerecor)** Series B · US **$32M** With 2 others
- **May** **[Proteon Therapeutics](https://millionrounds.com/company/proteon-therapeutics)** Series D · US **$45M** With 9 others
- **Apr** **[Iconic Therapeutics](https://millionrounds.com/company/iconic-therapeutics)** Series B · US **$20M** With 2 others
- **2013** 8 rounds
- **Nov** **[TriVascular](https://millionrounds.com/company/trivascular)** Series E · US · sec.gov **$40M** With 8 others
- **Oct** **[Sideris Pharmaceuticals](https://millionrounds.com/company/sideris-pharmaceuticals)** Series A · US · boston.com **$32M** With 2 others
- **Sept** **[iPierian](https://millionrounds.com/company/ipierian)** Series A · US · finsmes.com **$30M** With 2 others
- **Aug** **[Syndax Pharmaceuticals](https://millionrounds.com/company/syndax-pharmaceuticals)** Series B · US · finsmes.com **$27M** With 3 others
- **Jul** **[InformedDNA](https://millionrounds.com/company/informeddna)** Seed · US · online.wsj.com **$3.0M** Sole investor
- **Apr** **[Radius Health](https://millionrounds.com/company/radius-health)** Growth · US · finance.yahoo.com **$43M** With 5 others
- **Mar** **[Theraclone Sciences](https://millionrounds.com/company/theraclone-sciences)** Series B · US · finsmes.com **$8.0M** With 7 others
- **Mar** **[Nevro](https://millionrounds.com/company/nevro)** Series C · US · finsmes.com **$48M** With 8 others
- **2012** 11 rounds
- **Dec** **[23andMe](https://millionrounds.com/company/23andme)** Series D · US · sec.gov **$58M** With 5 others
- **Nov** **[Rhythm Pharmaceuticals](https://millionrounds.com/company/rhythm-pharmaceuticals)** Series B · US · pehub.com **$8.0M** With 4 others
- **Sept** **[Selexys Pharmaceuticals Corporation](https://millionrounds.com/company/selexys-pharmaceuticals-corporation)** Series A · US · finance.yahoo.com **$23M** Sole investor
- **Sept** **[Vascular Pharmaceuticals](https://millionrounds.com/company/vascular-pharmaceuticals)** Series A · US · finsmes.com **$16M** With 1 other
- **Jun** **[Rhythm Pharmaceuticals](https://millionrounds.com/company/rhythm-pharmaceuticals)** Series B · US · rhythmtx.com **$25M** With 3 others
- **Jun** **[Astute Medical](https://millionrounds.com/company/astute-medical)** Series C · US · finsmes.com **$40M** With 5 others
- **Jun** **[TriVascular](https://millionrounds.com/company/trivascular)** Series D · US · news.yahoo.com **$60M** With 6 others
- **May** **[NeoVista](https://millionrounds.com/company/neovista)** Venture · US **$6.0M** With 4 others
- **May** **[Celladon](https://millionrounds.com/company/celladon)** Venture · US · finsmes.com **$10M** Sole investor
- **Feb** **[Radius Health](https://millionrounds.com/company/radius-health)** Series C · US · onbiovc.com **$21M** With 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **10 named**

AK **Alan Kelly** Director i Filing they signed

AK **Ansbert Karl Gadicke** Dr. Gadicke is the Manager i Filing they signed

BM **Brendan Michael Furey** Chief Compliance Officer i Form ADV

CG **Christiana Goh Bardon** Dr. Bardon is the Managing Member of the General Partner of the Issuer and the Co-Managing Partner of MPM BioImpact LLC, the Investment Manager i Filing they signed

CW **Christopher Wolf** Mr. Wolf is the Chief Financial Officer and Authorized Signatory i Filing they signed

KL **Kristen Lee Laguerre** Ms. Laguerre is the Partner, Finance and Operations and Authorized Signatory i Filing they signed

LB **Luke Basil Evnin** Dr. Evnin is the Manager i Filing they signed

NR **Nicole Ramroop** Director i Filing they signed

RS **Robert Samuel Risoleo** General Counsel i Form ADV

TT **Todd Thomas Foley** Managing Director i Form ADV

We also hold **33** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$3.6B** assets it manages Oct 2026

**Registered** investment adviser full reporting to the SEC

- **Legal name:** MPM Asset Management LLC
- **SEC number:** CRD 148467

Funds on its Form ADV

**21** private funds, **$3.3B** in gross assets · filed Jun 2024

Venture **17** Hedge fund and venture capit **2** Hedge **2**

- Oncology Impact Fund 2, L.P. *Hedge fund and venture capit* 32 investors $826M
- UBS Oncology Impact Fund L.P. *Hedge fund and venture capit* 660 investors $721M
- MPM Bioventures 2018, L.P. *Venture* 43 investors $653M
- MPM Bioventures 2022, L.P. *Venture* 40 investors $345M
- MPM Oncology Innovations Fund L.P. *Venture* 36 investors $170M
- Bioimpact Equities Fund, L.P. *Hedge* 40 investors $154M
- MPM Bioventures 2014, L.P. *Venture* 61 investors $148M
- Bioimpact Equities Master Fund, L.P. *Hedge* 11 investors $99M
- MPM Bioventures IV-QP, L.P. *Venture* 68 investors $52M
- MPM Bioventures 2018 (B), L.P. *Venture* 8 investors $34M

And 11 more on the filing.

## What they claim to have backed

From their own portfolio page (on their website)

**6** of 11 we have independently watched raise

[AstronauTx](https://millionrounds.com/company/astronautx)[Cullinan Oncology](https://millionrounds.com/company/cullinan-oncology)[Frontier Medicines](https://millionrounds.com/company/frontier-medicines)[Reunion Neuroscience](https://millionrounds.com/company/reunion-neuroscience)[Umoja-biopharma](https://millionrounds.com/company/umoja-biopharma)[elevatebio](https://millionrounds.com/company/elevatebio) Aktis AshiBio Fable Photys Protego

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

## Exits from the portfolio

Companies it backed that were later bought or listed **23 in all**

**[iPierian](https://millionrounds.com/company/ipierian)** Bought by [Bristol-Myers Squibb](https://millionrounds.com/fund/bristol-myers-squibb) **$175M** Apr 2014

**[Ceregene](https://millionrounds.com/company/ceregene)** Bought by Sangamo BioSciences **Undisclosed** Aug 2013

**[Verastem](https://millionrounds.com/company/verastem)** Listed **$52M** Jul 2013

**[Conatus Pharmaceuticals](https://millionrounds.com/company/conatus-pharmaceuticals)** Listed **$69M** Jun 2013

**[Aratana Therapeutics](https://millionrounds.com/company/aratana-therapeutics)** Listed **$51M** May 2013

**[Epizyme](https://millionrounds.com/company/epizyme)** Listed **$60M** May 2013

**[Portola Pharmaceuticals](https://millionrounds.com/company/portola-pharmaceuticals)** Listed **$100M** May 2013

**[KaloBios Pharmaceuticals](https://millionrounds.com/company/kalobios-pharmaceuticals)** Listed **Undisclosed** Jan 2013

**[Xoft](https://millionrounds.com/company/xoft)** Bought by iCAD **$73M** Dec 2010

**[Alnara Pharmaceuticals](https://millionrounds.com/company/alnara-pharmaceuticals)** Bought by [Eli Lilly](https://millionrounds.com/fund/eli-lilly) **Undisclosed** Jul 2010

**[CGI Pharmaceuticals](https://millionrounds.com/company/cgi-pharmaceuticals)** Bought by [Gilead Sciences](https://millionrounds.com/fund/gilead-sciences) **$120M** Jun 2010

**[AVEO Pharmaceuticals](https://millionrounds.com/company/aveo-pharmaceuticals)** Listed **Undisclosed** Mar 2010

**[CHF Solutions](https://millionrounds.com/company/chf-solutions)** Bought by Gambro **Undisclosed** Jan 2010

**[Neuromed Pharmaceuticals](https://millionrounds.com/company/neuromed-pharmaceuticals)** Bought by Zalicus **Undisclosed** Dec 2009

**[Archus Orthopedics](https://millionrounds.com/company/archus-orthopedics)** Bought by Facet Solutions **Undisclosed** Nov 2009

**[Innovative Spinal Technologies](https://millionrounds.com/company/innovative-spinal-technologies)** Bought by Theken Spine **$9.3M** Sept 2009

**[Amphora Discovery](https://millionrounds.com/company/amphora-discovery)** Bought by Nanosyn **Undisclosed** Jul 2008

**[Tercica](https://millionrounds.com/company/tercica)** Bought by [Ipsen](https://millionrounds.com/fund/ipsen) **$480M** Jun 2008

**[CryoCor](https://millionrounds.com/company/cryocor)** Bought by [Boston Scientific](https://millionrounds.com/fund/boston-scientific) **Undisclosed** May 2008

**[Critical Therapeutics,Inc.](https://millionrounds.com/company/critical-therapeutics-inc)** Bought by Cornerstone Therapeutics **Undisclosed** May 2008

The latest 20 here. An exit counts when it came after the firm's first round in the company. From historical deal records.

## Companies it bought

Acquisitions by the firm itself

**Kourion Therapeutics** **Undisclosed** Jun 2001

New fund on file

**$407K**

raised in Jun 2026

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Pre-seed Seed Series A

Median round joined **$60M** the round, not its cheque Alone, median **$10M**

Led 2 of 139 rounds **1%**

- **Said size:** Up to $150M
- **Sole investor:** 8 rounds
- **Last cheque:** Dec 2025
- **Exits:** 23 from the portfolio

Rounds by stage said on their site

- Series B said *36*
- Series A said *33*
- Series C *31*
- Venture *16*
- Series D *15*
- Series E *4*
- Pre-seed said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 16
- [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) 13
- [HealthCare Ventures](https://millionrounds.com/fund/healthcare-ventures-llc) 13
- [Advanced Technology Ventures](https://millionrounds.com/fund/advanced-technology-ventures) 11
- [Abingworth](https://millionrounds.com/fund/abingworth) 10
- [OrbiMed](https://millionrounds.com/fund/orbimed) 10

**Pitching MPM Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as MPM Capital. A count of rooms they were both in, not a relationship either has claimed.

[**New Enterprise Associates** VC firm **16** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**ARCH Venture Partners** VC firm **13** rounds together](https://millionrounds.com/fund/arch-venture-partners)[**HealthCare Ventures** Growth equity **13** rounds together](https://millionrounds.com/fund/healthcare-ventures-llc)[**Advanced Technology Ventures** VC firm **11** rounds together](https://millionrounds.com/fund/advanced-technology-ventures)[**Abingworth** VC firm **10** rounds together](https://millionrounds.com/fund/abingworth)[**OrbiMed** Private equity **10** rounds together](https://millionrounds.com/fund/orbimed)[**Versant Ventures** VC firm **10** rounds together](https://millionrounds.com/fund/versant-ventures)[**Frazier Healthcare Partners** Private equity **9** rounds together](https://millionrounds.com/fund/frazier-healthcare-partners)[**Alta Partners** VC firm **7** rounds together](https://millionrounds.com/fund/alta-partners)[**Brookside Capital** Hedge fund **7** rounds together](https://millionrounds.com/fund/brookside-capital)[**Domain Associates** VC firm **7** rounds together](https://millionrounds.com/fund/domain-associates)[**Oxford Bioscience Partners** Growth equity **7** rounds together](https://millionrounds.com/fund/oxford-bioscience-partners)

## Recently backed

The latest companies MPM Capital put money into.

[**AstronauTx** $61M · Oct 2023](https://millionrounds.com/company/astronautx)[**Frontier Medicines** $67M · Jun 2019](https://millionrounds.com/company/frontier-medicines)

## Quick answers about MPM Capital

### What does MPM Capital invest in?

MPM Capital invests most often at Series B and Series A (51% of the rounds on record), in sectors such as Molecules, Ivd and Medical Devices.

### How active is MPM Capital?

139 investments on record, 1 of them in the last 12 months, and it led 2. The most recent was in Dec 2025.

### What has MPM Capital invested in recently?

Its most recent investments on record: Protego Biopharma (Series B, Dec 2025), AstronauTx (Series A, Oct 2023) and Tripley Therapeutics (Series A, Dec 2019).

### How big are MPM Capital's cheques?

The median round it joins is $60M.

### Does MPM Capital lead rounds?

Sometimes: it led 2 of its 139 investments on record (1%).

### Where does MPM Capital invest?

Most of the companies it backs are in the United States (97%).

### Is MPM Capital investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

### Who does MPM Capital invest alongside?

Most often New Enterprise Associates (16 rounds together), ARCH Venture Partners (13 rounds together) and HealthCare Ventures (13 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=mpm-bioimpact) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=mpm-bioimpact)